
OACC
Unit Split
OACC
First | 2024-12-23 | $9.98 | |
Recent | 2025-05-30 | $10.45 | 5% |
Oaktree Acquisition Corp. III Life Sciences
Sponsors:
- Registration2024-10-04 Filed S1
- IPO2024-10-25 IPO, search begins
- Definitive AgreementNo merger agreement yet
- CompletedNot yet completed
Leadership: John Frank, Zaid Pardesi, Aman Kumar, Mathew Pendo, Courtney Conigliaro, Paul Meister, Alvin Shih
Oaktree Acquisition Corp. III Life Sciences is a newly organized blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.
- Raised
- $175M
- CIK
- 2029769
- SPAC Ticker
- OACC
External link: SEC Filings SPAC Homepage